NPX Enema 4.5 FL OZ Two-Pack Recalled for Improper Storage
Family Dollar Stores is recalling NPX Enema 4.5 FL OZ 2-packs due to improper storage conditions that violate manufacturing standards. The product was held outside appropriate temperature conditions at select Family Dollar stores between April 30 and June 10, 2022.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: FDA Class II recall with no reported illnesses, injuries, or hospitalizations. The deviation involves improper storage conditions, which is a precautionary recall based on CGMP compliance concerns rather than documented harm.
Plain-English summary
Family Dollar Stores, LLC is recalling NPX Enema 4.5 FL OZ 2-pack bottles due to Current Good Manufacturing Practice (CGMP) deviations. The product was held outside appropriate storage temperature conditions, which may affect product quality and integrity.
The recalled product was distributed to specific Family Dollar Store locations nationwide between April 30, 2022, and June 10, 2022. The affected product is identified by SKU 915626.
Consumers should not use this product. If you have the recalled enema, stop using it and contact Family Dollar Stores for instructions on return or replacement. If you have any health concerns or questions, speak with a healthcare provider.
The recalled product
- Product
- NPX ENEMA 4.5 FL OZ 2 PK distributed to specific Family Dollar Stores 04/30/2022 through 06/10/2022.
- Manufacturer
- Family Dollar Stores, Llc.
- Category
- Drug — Over-the-Counter Medicine
- Hazard
- improper-storage
- cgmp-violation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- SKU: 915626
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27